Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29522
Title: No Association Between Lymphocyte Pharmacodynamics and Disability Following Alemtuzumab Treatment in patients With Relapsing-Remitting Multiple Sclerosis
Authors: Meuth, Sven G.
Brandes, David
Carraro, Matthew
Comi, Giancarlo
Mao-Draayer, Yang
Izquierdo, Guillermo
Kim, Ho Jin
Pardo, Gabriel
Sharrack, Basil
Tornatore, Carlo
VAN WIJMEERSCH, Bart 
Ziemssen, Tjalf
Jacobs, Alan
Chung, Luke
Daizadeh, Nadia
Wiendl, Heinz
Issue Date: 2019
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Source: NEUROLOGY, 92(15)
Notes: [Meuth, Sven G.; Wiendl, Heinz] Univ Munster, Munster, Germany. [Brandes, David] Hope MS Ctr, Knoxville, TN USA. [Carraro, Matthew] Novant Hlth, Charlotte, NC USA. [Comi, Giancarlo] Univ Vita Salute San Raffaele, Milan, Italy. [Mao-Draayer, Yang] Univ Michigan, Sch Med, Ann Arbor, MI USA. [Izquierdo, Guillermo] Virgen Macarena Univ Hosp, Seville, Spain. [Kim, Ho Jin] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea. [Pardo, Gabriel] Oklahoma Med Res Fdn, OMRF Multiple Sclerosis Ctr Excellence, 825 NE 13th St, Oklahoma City, OK 73104 USA. [Sharrack, Basil] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England. [Tornatore, Carlo] Georgetown Univ, Med Ctr, Washington, DC 20007 USA. [Van Wijmeersch, Bart] Hasselt Univ, Rehabil & MS Ctr Overpelt, BIOMED, Overpelt, Belgium. [Ziemssen, Tjalf] Carl Gustav Carus Univ Hosp, Ctr Clin Neurosci, Dresden, Germany. [Jacobs, Alan; Chung, Luke; Daizadeh, Nadia] Sanofi, Cambridge, MA USA.
Document URI: http://hdl.handle.net/1942/29522
ISSN: 0028-3878
e-ISSN: 1526-632X
ISI #: 000475965905020
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Show full item record

Page view(s)

46
checked on Jul 31, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.